An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients With Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-Grade Glioma.
Phase of Trial: Phase I
Latest Information Update: 17 May 2017
At a glance
- Drugs Cintredekin besudotox (Primary)
- Indications Glioma
- Focus Adverse reactions; Therapeutic Use